We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Serologicals Corporation (NASDAQ:SERO) announced today that its stockholders overwhelmingly approved the proposed acquisition of Serologicals by Millipore Corporation at a special...
Serologicals Corporation (NASDAQ:SERO), announced today that Celliance Corporation, its wholly-owned subsidiary, has entered into an exclusive agreement with Novozymes A/S to explore...
Serologicals Corporation (NASDAQ: SERO) today announced that Rashu Bhargava Seth, from the University of Texas Southwestern Medical Center at Dallas, has been named the 2006 Young Cell Signaller...
Serologicals Corporation (NASDAQ: SERO) today announced that five finalists from 83 entries have been chosen for its Upstate Group 2006 Young Cell Signaller Award. Entries were submitted...
Serologicals Corporation (NASDAQ: SERO) announced today that it has completed its previously announced acquisition of LINCO, a privately owned life sciences company focused on supplying...
Serologicals Corporation (NASDAQ: SERO) announced today its financial results for the first quarter ended April 2, 2006. Revenues decreased 2.8%, to $55.0 million, compared to $56.6 million in the...
Serologicals Corporation (NASDAQ: SERO) and the Australian Stem Cell Centre (ASCC) announced today that they have signed an agreement whereby Chemicon International, Inc., Serologicals...
Serologicals Corporation (NASDAQ: SERO) announced today that it will release its first quarter earnings on Wednesday, April 26, 2006 after the close of regular trading hours, and then host...
Firefly(TM) 3000 Assay Platform Monitored the Phosphorylation Forms of ERK PALO ALTO, Calif., April 12 /PRNewswire/ -- Researchers from MIT, supported by Cell BioSciences' just released Firefly...
Serologicals Corporation (NASDAQ: SERO) announced today that it has completed its previously announced acquisition of Cytomyx Ltd., a wholly owned subsidiary of Cytomyx Holdings Plc (AIM:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions